$28.40
+0.530 (+1.90%)
At Close: Jun 03, 2026
IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020
11:00am, Monday, 06'th Jan 2020
IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced that the company i
These new Bay Area stocks from 2019 are 'underwater' as year ends
03:48pm, Thursday, 26'th Dec 2019
One third of this year's Bay Area companies that went public in the past 12 months entered trading on the day after Christmas below their original offering prices.
Here’s What Hedge Funds Think About IDEAYA Biosciences, Inc. (IDYA)
11:30pm, Thursday, 19'th Dec 2019
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Se
IDEAYA Biosciences Appoints Wendy Yarno to its Board of Directors
11:00am, Wednesday, 18'th Dec 2019
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment o
Xconomy: Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO
12:19pm, Tuesday, 30'th Apr 2019
Do Wall Street investors believe that exosomes, the tiny bubbles once thought to be just cellular garbage bins, may be the key to treating a slew of
Sign In
Buy IDYA